Common Scientific Advisory Board (SAB) between CRKI and Karolinska CCC
A common international Scientific Advisory Board between Cancer Research KI and the Karolinska Comprehensive Cancer Center (Karolinska CCC) has been established. The board of directors of the KCCC, representing both the Karolinska Institute and The Karolinska University Hospital, aimed to incorporate advisory members with broad expertise in clinical, basic and caring cancer research; covering a varied set of cancer subdisciplines.
This common SAB will be able to advise on matters including, but not limited to, the long-term strategic development of research, education, care and prevention within cancer for both Cancer Research KI and the Karolinska CCC. The current members of the SAB are listed below in the table.
|Prof. Rupert Handgretinger||Medical Director and Chair at the Children’s University Hospital and Department of Haematology/Oncology, University of Tübingen||Germany|
|Prof. Nancy Berliner||Chief of the Division of Hematology, Brigham and Women's Hospital, as well as Professor at the Harvard Medical School||USA|
|Prof. Laura Esserman||Director of the University of California San Francisco (UCSF) Carol Franc Buck Breast Care Center and Professor of Surgery and Radiology at UCSF||USA|
|Prof. Eric Lartigau||General Director, Centre Oscar Lambret Lille as well as Professor in Radiation Oncology||France|
|Prof. Alison Richardson||Clinical Professor of Cancer Nursing and End of Life Care at the University of Southampton and University Hospital Southampton NHS Foundation Trust||UK|
|Prof. Erlend B. Smeland||Director research, education and innovation, Oslo University Hospital as well as Professor at the Medical Faculty, University of Oslo||Norway|
|Prof. Josep Tabernero||Director of Vall d´Hebron Institute of Oncology (VHIO), and Clinical Reasearch as well as Head of the Medical Oncology Department||Spain|
|Prof. Cornelis van de Veide||Professor of Surgery, Head of the Department of Surgical Oncology, Endocrine & Gastrointestinal Surgery at the Leiden University Medical Center||Netherlands|
|Prof. Julian Downward||Associate Research Director, the Francis Crick Institute in London||UK|